Chromosomal changes: induction, detection methods and applicability in human biomonitoring

Biochimie

Volumn 88, Issue 11, 2006, Pages 1515-1531

  Mateuca, R ^a   Lombaert, N ^a   Aka, P V ^a   Decordier, I ^a   Kirsch Volders, M ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Chromosomal aberration; Fluorescence in situ hybridization; Genetic polymorphisms; Micronuclei

Indexed keywords

CARCINOGEN;

AUTOMATION; BIOLOGICAL MONITORING; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CYTOGENETICS; ENVIRONMENT; FLOW CYTOMETRY; GENE IDENTIFICATION; GENOTOXICITY; HUMAN; IMAGE ANALYSIS; PERIPHERAL LYMPHOCYTE; REVIEW; WORK ENVIRONMENT;

CELL DIVISION; CHROMOSOME ABERRATIONS; ENVIRONMENTAL MONITORING; HUMANS; NEOPLASMS; SMOKING;

EID: 33751119273     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2006.07.004     Document Type: Review

References (121)

1. Kirsch-Volders M., Vanhauwaert A., Eichenlaub-Ritter U., and Decordier I. Indirect mechanisms of genotoxicity. Toxicol. Lett. 140-141 (2003) 63-74
2. Nias A.H.W. An Introduction to Radiobiology, second ed (1998), In Wiley, Chichester, England 4
3. Dowd S., and Tilson E. Practical Radiation Protectionand Applied Radiotherapy (1999), Saunders, Philadelphia PA, PA 118-120
4. Elhajouji A., Van Hummelen P., and Kirsch-Volders M. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen. 26 (1995) 292-304
5. Elhajouji A., Tibaldi F., and Kirsch-Volders M. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 12 (1997) 133-140
6. Decordier I., Dillen L., Cundari E., and Kirsch-Volders M. Elimination of micronucleated cells by apoptosis after treatment with inhibitors of microtubules. Mutagenesis 17 (2002) 337-344
7. Kirsch-Volders M., Vanhauwaert A., De Boeck M., and Decordier I. Importance of detecting numerical versus structural chromosome aberrations. Mutat. Res. 504 (2002) 137-148
8. Russell P.J. Chromosomal mutations. In: Cummings B. (Ed). Genetics (2002), Pearson Education Inc, San Francisco 595-621
9. Albertini R.J., Anderson D., Douglas G.R., Hagmar L., Hemminki K., Merlo F., Natarajan A.T., Norppa H., Shuker D.E., Tice R., Waters M.D., and Aitio A. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety, Mutat. Res. 463 (2000) 111-172
10. Hagmar L., Stromberg U., Bonassi S., Hansteen I.-L., Knudsen L.E., Lindholm C., and Norppa H. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res. 64 (2004) 2258-2263
11. Obe G., Pfeiffer P., Savage J.R., Johannes C., Goedecke W., Jeppesen P., Natarajan A.T., Martinez-Lopez W., Folle G.A., and Drets M.E. Chromosomal aberrations: formation, identification and distribution. Mutat. Res. 504 (2002) 17-36
12. Schwartz J.L., and Jordan R. Selective elimination of human lymphoid cells with unstable chromosome aberrations by p53-dependent apoptosis. Carcinogenesis 18 (1997) 201-205
13. Dean B.J., and Danford N. Assays for the detection of Chemically-induced chromosome damage in cultured mammalian cells. In: Venitt S., and Parry J.M. (Eds). Mutagenicity Testing-a Practical Approach (1984), IRL Press, Oxford 187-232
14. Vral A., Thierens H., and De Ridder L. In vitro micronucleus-centromere assay to detect radiation-damage induced by low doses in human lymphocytes. Int. J. Radiat. Biol. 71 1 (1997) 61-68
15. Touil N., Aka P.V., Buchet J.P., Thierens H., and Kirsch-Volders M. Assessment of genotoxic effects related to chronic low level exposure to ionizing radiation using biomarkers for DNA damage and repair. Mutagenesis 17 3 (2002) 223-232
16. Fenech M. Chromosomal damage rate, aging, and diet. Ann. N. Y. Acad. Sci. 854 (1998) 23-36
17. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol. Lett. 149 (2004) 309-334
18. Knudsen L.E., Norppa H., Gamborg M.O., Nielsen P.S., Okkels H., Soll-Johanning H., Raffn E., Jarventaus H., and Autrup H. Chromosomal aberrations in humans induced by urban air pollution: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 303-310
19. Norppa H., Bemardini S., Wikman H., Järventaus H., Rosenberg C., Bolognesi C., and Hirvonen A. Cytogenetic biomarkers in occupational exposure to dii socyanates: influence of genetic polymorphisms of metabolic enzymes. Environ. Mol. Mutag. 35 Suppl. 31 (2000) 45
20. Norppa H., Lindholm C., Ojajärvi A., Salomaa S., and Hirvonen A. Metabolic polymorphisms and frequency of chromosomal aberrations. Environ. Mol. Mutag. 37 Suppl. 32 (2001) 58
21. Tuimala J., Szekely G., Wikman H., Jarventaus H., Hirvonen A., Gundy S., and Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations. Mutat. Res. 554 (2004) 319-333
22. Landi S., Norppa H., Frenzilli G., Cipollini G., Ponzanelli I., Barale R., and Hirvonen A. Individual sensitivity to cytogenetic effects of 1,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics 8 (1998) 461-471
23. Sram R.J., Rossner P., Peltonen K., Podrazilova K., Mrackova G., Demopoulos N.A., Stephanou G., Vlachodimitropoulos D., Darroudi F., and Tates A.D. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1, 3-butadiene-exposed workers. Mutat. Res. 419 (1998) 145-154
24. Sorsa M., Osterman-Golkar S., Peltonen K., Saarikoski S.T., and Sram R. Assessment of exposure to butadiene in the process industry. Toxicology 113 (1996) 77-83
25. Vodicka P., Soucek P., Tates A.D., Dusinska M., Sarmanova J., Zamecnikova M., Vodickova L., Koskinen M., de Zwart F.A., Natarajan A.T., and Hemminki K. Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat. Res. 482 (2001) 89-103
26. Vodicka P., Kumar R., Soucek P., Haufroid V., Stetina R., Dusinska M., Kuricova M., Zamenikova M., Buchanova J., Norppa H., Vodickova L., Matousu Z., and Hemminki K. Genetic polymorphisms of DNA repair and biotransformation genes and possible links with chromosomal aberrations and single-strand breaks in DNA. Toxicol. Lett. 144 Suppl. 1 (2003) s154
27. Migliore L., Naccarati A., Coppede F., Bergamaschi E., De Palma G., Voho A., Manini P., Jarventaus H., Mutti A., Norppa H., and Hirvonen A. Cytogenetic biomarkers, urinary metabolites and metabolic gene polymorphisms in workers exposed to styrene. Pharmacogenet. Genomics 16 (2006) 87-99
28. Pluth J.M., Ramsey M.J., and Tucker J.D. Role of maternal exposures and newborn genotypes on newborn chromosome aberration frequencies. Mutat. Res. 465 (2000) 101-111
29. Abdel-Rahman S.Z., Salama S.A., Au W.W., and Hamada F.A. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes. Pharmacogenetics 10 (2000) 239-249
30. Vodicka P., Kumar R., Stetina R., Sanyal S., Soucek P., Haufroid V., Dusinska M., Kuricova M., Zamecnikova M., Musak L., Buchancova J., Norppa H., Hirvonen A., Vodickova L., Naccarati A., Matousu Z., and Hemminki K. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 25 (2004) 757-763
31. Affatato A.A., Wolfe K.J., Lopez M.S., Hallberg C., Ammenheuser M.M., and Abdel-Rahman S.Z. Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ. Mol. Mutagen. 44 (2004) 65-73
32. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 567 (2004) 447-474
33. Bender M.A., Preston R.J., Leonard R.C., Pyatt B.E., Gooch P.C., and Shelby M.D. Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. Mutat. Res. 204 (1988) 421-433
34. van Diemen P.C., Maasdam D., Vermeulen S., Darroudi F., and Natarajan A.T. Influence of smoking habits on the frequencies of structural and numerical chromosomal aberrations in human peripheral blood lymphocytes using the fluorescence in situ hybridization (FISH) technique. Mutagenesis 10 (1995) 487-495
35. Nordic Study Group on the Health Risk of Chromosome Damage. A Nordic data base on somatic chromosome damage in humans. Mutat. Res. 241 (1990) 325-337
36. Ramsey M.J., Moore II D.H., Briner J.F., Lee D.A., Olsen L., Senft J.R., and Tucker J.D. The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat. Res. 338 (1995) 95-106
37. Littlefield L.G., and Joiner E.E. Analysis of chromosome aberrations in lymphocytes of long-term heavy smokers. Mutat. Res. 170 (1986) 145-150
38. Sinues B., Izquierdo M., and Perez Viguera J. Chromosome aberrations and urinary thioethers in smokers. Mutat. Res. 240 (1990) 289-293
39. Tawn E.J., and Whitehouse C.A. Frequencies of chromosome aberrations in a control population determined by G banding. Mutat. Res. 490 (2001) 171-177
40. Sorsa M., Husgafvel-Pursiainen K., Jarventaus H., Koskimies K., Salo H., and Vainio H. Cytogenetic effects of tobacco smoke exposure among involuntary smokers. Mutat. Res. 222 (1989) 111-116
41. Husgafvel-Pursiainen K. Genotoxicity of environmental tobacco smoke: a review. Mutat. Res. 567 (2004) 427-445
42. Chen A.T., Reidy J.A., Annest J.L., Welty T.K., and Zhou H.G. Increased chromosome fragility as a consequence of blood folate levels, smoking status, and coffee consumption. Environ. Mol. Mutagen. 13 (1989) 319-324
43. Bonassi S., Hagmar L., Stromberg U., Huici-Montagud A., Tinnerberg H., Forni A., Heikkilä P., Wanders S., Wilhardt P., Hansteen I.-L., Knudsen L., Norppa H., and and the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res. 60 (2000) 1619-1625
44. Mao L., Lee J.S., Kurie J.M., Fan Y.H., Lippman S.M., Lee J.J., Ro J.Y., Broxson A., Yu R., Morice R.C., Kemp B., Khuri F.R., Walsh G.L., Hittelman W.N., and Hong W.K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. 89 (1997) 834-836
45. Kao-Shan C.S., Fine R.L., Whang-Peng J., Lee E.C., and Chabner B.A. Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res. 47 (1987) 6278-6282
46. Sanzchez-Cespedes M., Ahrendt S.A., Piantadosi S., Rosell R., Monzo M., Wu L., Westra W.H., Yang S.C., Jen J., and Sidransky D. Chromosomal alterations in lung adenocracinoma from smokers and nonsmokers. Cancer Res. 61 (2001) 1309-1313
47. Bonassi S., and Au W.W. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat. Res. 511 (2002) 73-86
48. Hagmar L., Bonassi S., Strömberg U., Brøgger A., Knudsen L.S., Norppa H., and Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res. 58 (1998) 4117-4121
49. Hagmar L., Bonassi S., Strömberg U., Mikoczy Z., Lando C., Hansteen I.-L., Huici-Montagud A., Knudsen L., Norppa H., Reuterwall C., Tinnerberg H., Brøgger A., Forni A., Högstedt B., Lambert B., Mitelman F., Nordenson I., Salomaa S., and Skerfving S. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat. Res. 405 (1998) 171-178
50. Hagmar L., Bonassi S., Strömberg U., Mikoczy Z., Lando C., Hansteen I.-L., Huici-Montagut A., Knudsen L.E., Norppa H., Reuterwall C., Tinnerberg H., Brøgger A., Forni A., Högstedt B., Lambert B., Mitelman F., Nordenson I., Salomaa S., and Skerfving S. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs. Recent Results Cancer Res 154 (1998) 177-184
51. Hagmar L., Brogger A., Hansteen I.-L., Heim S., Högstedt B., Knudsen L., Lambert B., Linnainmaa K., Mitelman F., Nordenson I., Reuterwall C., Salomaa S., Skerfving S., and Sorsa M. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 54 (1994) 2919-2922
52. Liou S.H., Lung J.C., Chen Y.H., Yang T., Hsieh L.L., Chen C.J., and Wu T.N. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res. 59 (1999) 1481-1484
53. Fenech M., and Morley A.A. Measurement of micronuclei in lymphocytes. Mutat. Res. 147 (1985) 29-36
54. Fenech M. The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 20 (2005) 255-269
55. Thomas P., Umegaki K., and Fenech M. Nucleoplasmic bridges are a sensitive measure of chromosome rearrangement in the cytokinesis-block micronucleus assay. Mutagenesis 18 (2003) 187-194
56. Fenech M., Baghurst P., Luderer W., Turner J., Record S., Ceppi M., and Bonassi S. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability-results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 26 (2005) 991-999
57. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov. Today 7 (2002) 1128-1137
58. Cimini D., and Degrassi F. Aneuploidy: a matter of bad connections. Trends Cell Biol. 15 (2005) 442-451
59. Leach N.T., and Jackson-Cook C. Micronuclei with multiple copies of the X chromosome: do chromosomes replicate in micronuclei?. Mutat. Res. 554 (2004) 89-94
60. Elhajouji A., Cunha M., and Kirsch-Volders M. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 13 (1998) 193-198
61. Kirsch-Volders M., and Fenech M. Inclusion of micronuclei in non-divided mononuclear lymphocytes and necrosis/apoptosis may provide a more comprehensive cytokinesis block micronucleus assay for biomonitoring purposes. Mutagenesis 16 (2001) 51-58
62. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Jr Ishidate M., Kirchner S., Lorge E., Morita T., Norppa H., Surralles J., Vanhauwaert A., and Wakata A. Report from the in vitro micronucleus assay working group. Mutat. Res. 540 (2003) 153-163
63. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Jr Ishidate M., Lorge E., Norppa H., Surralles J., von der Hude W., and Wakata A. Corrigendum to "Report from the in vitro micronucleus assay working group". Mutat. Res. 564 (2004) 97-100 (Mutat. Res. 540 (2003) 153-163)
64. Fenech M., Holland N., Chang W.P., Zeiger E., and Bonassi S. The Human MicroNucleus project-an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat. Res. 428 (1999) 271-283
65. Fenech M. The in vitro micronucleus technique. Mutat. Res. 455 (2000) 81-95
66. Norppa H., and Falck G.C. What do human micronuclei contain?. Mutagenesis 18 (2003) 221-233
67. Kimura M., Umegaki K., Higuchi M., Thomas P., and Fenech M. Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J. Nutr. 134 (2004) 48-56
68. Kirsch-Volders M., Elhajouji A., Cundari E., and Van Hummelen P. The in vitro micronucleus test: a multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutat. Res. 392 (1997) 19-30
69. Bonassi S., Fenech M., Lando C., Lin Y.-P., Ceppi M., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Jia C., Di Giorgio M., Ferguson L.R., Fucic A., Lima O.G., Hrelia P., Krishnaja A.P., Lee T.-K., Migliore L., Mikhalevich L., Mirkova E., Mosesso P., Müller W.-U., Odagiri Y., Scarffi M.R., Szabova E., Vorobtsova I., et al. Human MicroNucleus Project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ. Mol. Mutagen. 37 (2001) 31-45
70. Fenech M., Neville S., and Rinaldi J. Sex is an important variable affecting spontaneous micronucleus frequency in cytokinesis-blocked lymphocytes. Mutat. Res. 313 (1994) 203-207
71. Surralles J., Jeppesen P., Morrison H., and Natarajan A.T. Analysis of loss of inactive X chromosomes in interphase cells. Am. J. Hum. Genet. 59 (1996) 1091-1096
72. Surralles J., Hande M.P., Marcos R., and Lansdorp P.M. Accelerated telomere shortening in the human inactive X chromosome. Am. J. Hum. Genet. 65 (1999) 1617-1622
73. Hando J., Nath J., and Tucker J. Sex chromosomes, micronuclei and aging in women. Chromosoma 103 (1994) 186-192
74. Nath J., Tucker J., and Hando J. Y chromosome aneuploidy, micronuclei, kinetochores and aging in men. Chromosoma 103 (1995) 725-731
75. Fitzgerald P. Premature centromere division of the X chromosome. In: Sandberg A. (Ed). Cytogenetics of the Mammalian X Chromosome. Part B. X Chromosome Anomalies and Their Clinical Manifestations (1983), Liss, New York 171-184
76. Hando J.C., Tucker J.D., Davenport M., Tepperberg J., and Nath J. X chromosome inactivation and micronuclei in normal and Turner individuals. Hum. Genet. 5-6 (1997) 624-628
77. Tucker J., Nath J., and Hando J. Activation status of the X chromosome in human micronucleated lymphocytes. Hum. Genet. 97 (1996) 471-475
78. Neri M., Ceppi M., Knudsen L., Merlo D.F., Barale R., Puntoni R., and Bonassi S. Baseline micronuclei frequency in children: estimates from meta- and pooled analyses. Environ. Health Perspect. 113 (2005) 1226-1229
79. Kirsch-Volders M., Mateuca R.A., Roelants M., Tremp A., Zeiger E., Bonassi S., Holland N., Chang W.P., Aka P.V., DeBoeck M., Godderis L., Haufroid V., Ishikawa H., Laffon B., Marcos R., Migliore L., Norppa H., Teixeira J.P., Zijno A., and Fenech M. The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo. Cancer Epidemiol. Biomarkers Prev. 15 5 (2006) 1038-1042
80. Iarmarcovai G., Sari-Minodier I., Orsiere T., De Meo M., Gallice P., Bideau C., Iniesta D., Pompili J., Berge-Lefranc J.L., and Botta A. A combined analysis of XRCC1, XRCC3, GSTM1 and GSTT1 polymorphisms and centromere content of micronuclei in welders. Mutagenesis 21 (2006) 159-165
81. Ishikawa H., Yamamoto H., Tian Y., Kawano M., Yamauchi T., and Yokoyama K. Evidence of association of the CYP2E1 genetic polymorphism with micronuclei frequency in human peripheral blood. Mutat. Res. 546 (2004) 45-53
82. Scarpato R., Migliore L., Hirvonen A., Falck G., and Norppa H. Cytogenetic monitoring of occupational exposure to pesticides: characterization of GSTM1, GSTT1, and NAT2 genotypes. Environ. Mol. Mutagen. 27 (1996) 263-269
83. Aka P., Mateuca R., Buchet J.P., Thierens H., and Kirsch-Volders M. Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations?. Mutat. Res. 556 (2004) 169-181
84. Mateuca R., Aka P.V., De Boeck M., Hauspie R., Kirsch-Volders M., and Lison D. Influence of hOGG1, XRCC1 and XRCC3 genotypes on biomarkers of genotoxicity in workers exposed to cobalt or hard metal dusts. Toxicol. Lett. 156 (2005) 277-288
85. Iarmarcovai G., Sari-Minodier I., Chaspoul F., Botta C., De Meo M., Orsiere T., Berge-Lefranc J.L., Gallice P., and Botta A. Risk assessment of welders using analysis of eight metals by ICP-MS in blood and urine and DNA damage evaluation by the comet and micronucleus assays; influence of XRCC1 and XRCC3 polymorphisms. Mutagenesis 20 (2005) 425-432
86. Angelini S., Kumar R., Carbone F., Maffei F., Forti G.C., Violante F.S., Lodi V., Curti S., Hemminki K., and Hrelia P. Micronuclei in humans induced by exposure to low level of ionizing radiation: influence of polymorphisms in DNA repair genes. Mutat. Res. 570 (2005) 105-117
87. Crott J.W., Mashiyama S.T., Ames B.N., and Fenech M. The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1089-1096
88. Zijno A., Andreoli C., Leopardi P., Marcon F., Rossi S., Caiola S., Verdina A., Galati R., Cafolla A., and Crebelli R. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis 24 (2003) 1097-1103
89. Rajagopalan H., Jallepalli P.V., Rago C., Velculescu V.E., Kinzler K.W., Vogelstein B., and Lengauer C. Inactivation of hCDC4 can cause chromosomal instability. Nature 428 (2004) 77-81
90. Fenech M.F., Dreosti I.E., and Rinaldi J.R. Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men. Carcinogenesis 18 (1997) 1329-1336
91. Fenech M., Aitken C., and Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 19 (1998) 1163-1171
92. Fenech M., and Rinaldi J. A comparison of lymphocyte micronuclei and plasma micronutrients in vegetarians and non-vegetarians. Carcinogenesis 16 (1995) 223-230
93. Fenech M., Dreosti I., and Aitken C. Vitamin-E supplements and their effect on Vitamin-E status in blood and genetic damage rate in peripheral blood lymphocytes. Carcinogenesis 18 (1997) 359-364
94. Odagiri Y., and Uchida H. Influence of serum micronutrients on the incidence of kinetochore-positive or-negative micronuclei in human peripheral blood lymphocytes. Mutat. Res. 415 (1998) 35-45
95. Titenko-Holland N., Jacob R.A., Shang N., Balaraman A., and Smith M.T. Micronuclei in lymphocytes and exfoliated buccal cells of postmenopausal women with dietary changes in folate. Mutat. Res. 417 (1998) 101-114
96. Fenech M. Nutritional treatment of genome instability: a paradigm shift in disease prevention and in the setting of recommended dietary allowances. Nutr. Res. Rev. 16 (2003) 109-122
97. Bonassi S., Neri M., Lando C., Ceppi M., Lin Y.-P., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Fenech M., and and the HUMN collaborative group. Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus project. Mutat. Res. 543 (2003) 155-166
98. Miller B., Albertini S., Locher F., Thybaud V., and Lorge E. Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: industrial experience. Mutat. Res. 392 (1997) 187-208
99. Albertini S., Miller B., Chetelat A.A., and Locher F. Detailed data on in vitro MNT and in vitro CA: industrial experience. Mutat. Res. 392 (1997) 187-208
100. Miller B., Pötter-Locher F., Seelbach A., Stopper H., Utesch D., and Madle S. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group on the in vitro micronucleus test. Mutat. Res. 410 (1998) 81-116
101. Matsushima T., Hayashi M., Matsuoka A., Ishidate Jr. M., Miura K.F., Shimizu H., Suzuki Y., Morimoto K., Ogura H., Mure K., Koshi K., and Sofuni T. Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis 14 (1999) 569-580
102. von der Hude W., Kalweit S., Engelhardt G., McKiernan S., Kasper P., Slacik-Erben R., Miltenburger H.G., Honarvar N., Fahrig R., Gorlitz B., Albertini S., Kirchner S., Utesch D., Potter-Locher F., Stopper H., and Madle S. In vitro micronucleus assay with Chinese hamster V79 cells-results of a collaborative study with in situ exposure to 26 chemical substances. Mutat. Res. 468 2 (2000) 137-163
103. Duffaud F., Orsiere T., Villani P., Pelissier A.L., Volot F., Favre R., and Botta A. Comparison between micronucleated lymphocyte rates observed in healthy subjects and cancer patients. Mutagenesis 12 (1997) 227-231
104. Rudd N.L., Hoar D.I., Greentree C.L., Dimnik L.S., and Hennig U.G. Micronucleus assay in human fibroblasts: a measure of spontaneous chromosomal instability and mutagen hypersensitivity. Environ. Mol. Mutagen. 12 (1988) 3-13
105. Rosin M.P., and German J. Evidence for chromosome instability in vivo in Bloom syndrome: increased numbers of micronuclei in exfoliated cells. Hum. Genet. 71 (1985) 187-191
106. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., and Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA 94 (1997) 3290-3295
107. Olaharski A.J., Sotelo R., Solorza-Luna G., Gonsebatt M.E., Guzman P., Mohar A., and Eastmond D. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27 (2006) 337-343
108. Bonassi S., Ugolini D., Kirsch-Volders M., Stromberg U., Vermeulen R., and Tucker J.D. Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environ. Mol. Mutagen. 45 2-3 (2005) 258-270
109. Speicher M.R., and Carter N.P. The new cytogenetics: blurring the boundaries with molecular biology. Nat. Rev. Genet. 6 10 (2005) 782-792
110. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., and Ried T. Multicolor spectral karyotyping of human chromosomes. Science 26-273 5274 (1996) 494-497
111. Speicher M.R., and Ward D.C. The coloring of cytogenetics. Nat. Med. 2 9 (1996) 1046-1048
112. Horstmann M., and Obe G. CABAND: classification of aberrations in multicolor banded chromosomes. Cytogenet. Genome Res. 103 1-2 (2003) 24-27
113. Chudoba I., Hickmann G., Friedrich T., Jauch A., Kozlowski P., and Senger G. mBAND: a high resolution multicolor banding technique for the detection of complex intrachromosomal aberrations. Cytogenet. Genome Res. 104 1-4 (2004) 390-393
114. Huber R., Kulka U., Lorch T., Braselmann H., and Bauchinger M. Automated metaphase finding: an assessment of the efficiency of the METAFER2 system in a routine mutagenicity assay. Mutat. Res. 334 (1995) 97-102
115. Odawara K., Yamamoto K., Kato H., Hara M., Kogiso S., Kishida F., Yoshitake A., and Nakatsuka I. A new semi-automated chromosome analysis system for in vitro chromosomal aberration tests. Mutat. Res. 389 (1997) 207-212
116. Abrahamsson-Zetterberg L. The dose-response relationship at very low doses of acrylamide is linear in the flow cytometer-based mouse micronucleus assay. Mutat. Res. 535 2 (2003) 215-222
117. Verhaegen F., Vral A., Seuntjens J., Schipper N.W., de Ridder L., and Thierens H. Scoring of radiation-induced micronuclei in cytokinesisblocked human lymphocytes by automated image analysis. Cytometry 17 (1994) 119-127
118. Schunck C., Johannes T., Varga D., Lorch T., and Plesch A. New developments in automated cytogenetic imaging: unattended scoring of dicentric chromosomes, micronuclei, single cell gel electrophoresis, and fluorescence signals. Cytogenet. Genome Res. 104 (2004) 383-389
119. Smolewski P., Ruan Q., Vellon L., and Darzynkiewicz Z. Micronuclei assay by laser scanning cytometry. Cytometry 45 (2001) 19-26
120. Castelain P., Van Hummelen P., Deleener A., and Kirsch-Volders M. Automated detection of cytochalasin-B blocked binucleated lymphocytes for scoring micronuclei. Mutagenesis 8 4 (1993) 285-293
121. Van Hummelen P., Nusse N., Castelain P., and Kirsch-Volders M. DNA content of micronuclei measured by image analysis in human lymphocytes can be used to identify aneugens if the cell cycle stage is taken into account. Environ. Mol. Mutagen. 25 (1995) 269-278